Literature DB >> 6397451

Central nervous system infections in the immunocompromised host.

D Armstrong.   

Abstract

Central nervous system (CNS) infections in the immunocompromised host are predictable according to the arm of the immune defense which is most defective. A limited number of organisms with a tendency to cause CNS infections will take advantage of the different types of immune defects. Signs and symptoms of CNS infection are often quite subtle in the immunocompromised host because of the diminished inflammatory response. Serologic responses may not be as reliable as in a normal host. Aggressive diagnostic approaches are often necessary, including early brain biopsy and abscess drainage. Aggressive therapy is often also necessary, including multiple potentially toxic antibiotics and devices to deliver them, such as indwelling intraventricular reservoirs. The role of the third generation cephalosporins is still not clear, and certainly they should not be used alone to treat aerobic gram-negative rod meningitis in neutropenic patients. Patients with the acquired immune deficiency syndrome (AIDS) have developed CNS infections with familiar agents producing familiar syndromes. The main CNS infection, however, is a subacute encephalitis and the causative agent remains undocumented.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6397451     DOI: 10.1007/BF01641746

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  9 in total

1.  Central nervous system infections in patients with cancer. Changing patterns.

Authors:  N L Chernik; D Armstrong; J B Posner
Journal:  Cancer       Date:  1977-07       Impact factor: 6.860

2.  Central nervous system infections in patients with cancer.

Authors:  N L Chernik; D Armstrong; J B Posner
Journal:  Medicine (Baltimore)       Date:  1973-11       Impact factor: 1.889

3.  IgM antibodies in acute toxoplasmosis. II. Prevalence and significance in acquired cases.

Authors:  J S Remington; M J Miller; I Brownlee
Journal:  J Lab Clin Med       Date:  1968-05

Review 4.  Central nervous system infections in immunocompromised hosts.

Authors:  D Armstrong; B Wong
Journal:  Annu Rev Med       Date:  1982       Impact factor: 13.739

Review 5.  Central nervous system infection in the chronically immunosuppressed.

Authors:  D C Hooper; A A Pruitt; R H Rubin
Journal:  Medicine (Baltimore)       Date:  1982-05       Impact factor: 1.889

6.  Toxoplasmosis. Problems in diagnosis and treatment.

Authors:  T B Hakes; D Armstrong
Journal:  Cancer       Date:  1983-10-15       Impact factor: 6.860

7.  Bacterial infections of the CNS in neutropenic patients.

Authors:  S A Lukes; J B Posner; S Nielsen; D Armstrong
Journal:  Neurology       Date:  1984-03       Impact factor: 9.910

8.  Central-nervous-system toxoplasmosis in homosexual men and parenteral drug abusers.

Authors:  B Wong; J W Gold; A E Brown; M Lange; R Fried; M Grieco; D Mildvan; J Giron; M L Tapper; C W Lerner
Journal:  Ann Intern Med       Date:  1984-01       Impact factor: 25.391

9.  Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients.

Authors:  W D Snider; D M Simpson; S Nielsen; J W Gold; C E Metroka; J B Posner
Journal:  Ann Neurol       Date:  1983-10       Impact factor: 10.422

  9 in total
  1 in total

1.  Toll-like receptor prestimulation increases phagocytosis of Escherichia coli DH5alpha and Escherichia coli K1 strains by murine microglial cells.

Authors:  Sandra Ribes; Sandra Ebert; Dirk Czesnik; Tommy Regen; Andre Zeug; Stephanie Bukowski; Alexander Mildner; Helmut Eiffert; Uwe-Karsten Hanisch; Sven Hammerschmidt; Roland Nau
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.